Intensity Therapeutics, Inc.
INTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $24,476 | $73,842 | $78,072 | $78,072 |
| - Cash | $2,590 | $8,556 | $1,312 | $4,539 |
| + Debt | $138 | $158 | $4,492 | $2,343 |
| Enterprise Value | $22,024 | $65,444 | $81,252 | $75,876 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$147 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$16,268 | -$10,086 | -$7,500 | -$7,878 |
| % Margin | – | – | – | – |
| Net Income | -$16,268 | -$10,538 | -$7,582 | -$7,896 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.17 | -0.87 | -0.58 | -0.6 |
| % Growth | -34.5% | -50% | 3.3% | – |
| Operating Cash Flow | -$15,220 | -$7,205 | -$5,477 | -$6,827 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$15,220 | -$7,205 | -$5,477 | -$6,827 |